The purpose of the present invention is to provide novel compounds having ACC2 selective inhibitory activity. In addition, the present invention provides a pharmaceutical composition comprising the compound. A compound of Formula:or its pharmaceutically acceptable salt,wherein, R1 is substituted or unsubstituted fused aromatic heterocyclyl represented by Formula:wherein,ring B is 5-membered ring, ring C is 6-membered ringring A is substituted or unsubstituted non-aromatic carbocycle or the like-L1- is -O-(CR6R7)m- or the like-L2- is -O-(CR6R7)n- or the likeeach R6 is independently hydrogen or the likeeach R7 is independently hydrogen or the likeeach m is independently an integer of 0, 1, 2 or 3each n is independently an integer of 1, 2 or 3R2 is substituted or unsubstituted alkylR3 is hydrogen or substituted or unsubstituted alkylR4 is substituted or unsubstituted alkylcarbonyl or the like.
